13F
中

SKYE SKYE BIOSCIENCE INC

2026Q1 · CUSIP 83086J200 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
38
Δ holders QoQ
-12
Breadth percentile
Top 88%
Whale holders
18
Δ whales
-5
Inst. holding value
$10M
New positions
5
Closed positions
17
Price momentum (1Q)
—
Put / Call
1/1

Breadth history (34 quarters)

2024Q2: Δ+60 · h=63 2024Q3: Δ+12 · h=75 2024Q4: Δ-1 · h=74 2025Q1: Δ+2 · h=76 2025Q2: Δ-17 · h=59 2025Q3: Δ-1 · h=58 2025Q4: Δ-8 · h=50 2026Q1: Δ-12 · h=38 2024Q2: holders=63 2024Q3: holders=75 2024Q4: holders=74 2025Q1: holders=76 2025Q2: holders=59 2025Q3: holders=58 2025Q4: holders=50 2026Q1: holders=38 -60 -30 +0 +30 +60 345780 24Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q2 Top 2% +18.2% -31.8%

Options Sentiment

Put holders
1
QoQ: 0
Call holders
1
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.45
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2024-03-31: EPS -0.18 2024-06-30: EPS -0.20 2024-09-30: EPS -0.10 2024-12-31: EPS -0.25 2025-03-31: EPS -0.28 2025-06-30: EPS -0.44 2025-09-30: EPS -0.32 2025-12-31: EPS -0.37 2026-03-31: EPS -0.32 -0.48 -0.24 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)